Girard, N.; Besada, M.; Rogula, B.; Lucherini, S.; Vo, L.; Chaudhary, M.A.; Goring, S.; Lozano-Ortega, G.; Tran, M.; Varol, N.;
et al. Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492. Cancers 2025, 17, 674.
https://doi.org/10.3390/cancers17040674
AMA Style
Girard N, Besada M, Rogula B, Lucherini S, Vo L, Chaudhary MA, Goring S, Lozano-Ortega G, Tran M, Varol N,
et al. Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492. Cancers. 2025; 17(4):674.
https://doi.org/10.3390/cancers17040674
Chicago/Turabian Style
Girard, Nicolas, Mariam Besada, Basia Rogula, Stefano Lucherini, Lien Vo, Mohammad A. Chaudhary, Sarah Goring, Greta Lozano-Ortega, Mia Tran, Nebibe Varol,
and et al. 2025. "Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492" Cancers 17, no. 4: 674.
https://doi.org/10.3390/cancers17040674
APA Style
Girard, N., Besada, M., Rogula, B., Lucherini, S., Vo, L., Chaudhary, M. A., Goring, S., Lozano-Ortega, G., Tran, M., Varol, N., Waser, N., Yu, W. W., Lee, J. M., & Spicer, J.
(2025). Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492. Cancers, 17(4), 674.
https://doi.org/10.3390/cancers17040674
